{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:19Z","timestamp":1792787899749,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["Grants 82360517, 82060450, 81460374, 31460304"],"award-info":[{"award-number":["Grants 82360517, 82060450, 81460374, 31460304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nature Science Foundation of Jiangxi province of China","award":["20232BAB206086, 20192BAB205072, 20203BBGL73206, 2017BCB23086, 2017BAB205062, 2018BAB205050"],"award-info":[{"award-number":["20232BAB206086, 20192BAB205072, 20203BBGL73206, 2017BCB23086, 2017BAB205062, 2018BAB205050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04485-8","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T01:34:25Z","timestamp":1765503265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical significance of the S204 phosphorylation of the Smad3 protein in combination with Ki67 for the metastasis and prognosis of gastric cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Yi-Hui","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Lin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Yu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"4485_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"4485_CR2","volume":"39","author":"RM Feng","year":"2019","unstructured":"Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun (Lond). 2019;39:22.","journal-title":"Cancer Commun (Lond)"},{"key":"4485_CR3","first-page":"264","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71:264\u201379.","journal-title":"CA Cancer J Clin"},{"key":"4485_CR4","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/jso.25220","volume":"118","author":"P Li","year":"2018","unstructured":"Li P, Huang C-M, Zheng C-H, Russo A, Kasbekar P, Brennan MF, et al. Comparison of gastric cancer survival after R0 resection in the US and China. J Surg Oncol. 2018;118:975\u201382.","journal-title":"J Surg Oncol"},{"key":"4485_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1023\/A:1008243606668","volume":"8","author":"B Glimelius","year":"1997","unstructured":"Glimelius B, Ekstr\u00f6m K, Hoffman K, Graf W, Sj\u00f6d\u00e9n PO, Haglund U, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol. 1997;8:163\u20138.","journal-title":"Ann Oncol"},{"key":"4485_CR6","doi-asserted-by":"publisher","first-page":"948647","DOI":"10.3389\/fimmu.2022.948647","volume":"13","author":"X Jin","year":"2022","unstructured":"Jin X, Liu Z, Yang D, Yin K, Chang X. Recent progress and future perspectives of immunotherapy in advanced gastric cancer. Front Immunol. 2022;13:948647.","journal-title":"Front Immunol"},{"key":"4485_CR7","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.21037\/jgo-24-210","volume":"15","author":"X Gu","year":"2024","unstructured":"Gu X, Rong J, Zhu L, Dai Z, Ren S, Chen J, et al. Hepatoid adenocarcinoma of the stomach: discrimination from conventional gastric adenocarcinoma with a computed tomography-based radiomics nomogram. J Gastrointest Oncol. 2024;15:2041\u201352.","journal-title":"J Gastrointest Oncol"},{"key":"4485_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1222853","volume":"13","author":"C Dong","year":"2023","unstructured":"Dong C, Wang Y, Gu X, Lv X, Ren S, Wang Z, et al. Differential diagnostic value of tumor markers and contrast-enhanced computed tomography in gastric hepatoid adenocarcinoma and gastric adenocarcinoma. Front Oncol. 2023;13:1222853.","journal-title":"Front Oncol"},{"key":"4485_CR9","first-page":"117","volume":"43","author":"M Duchrow","year":"1995","unstructured":"Duchrow M, Schl\u00fcter C, Key G, Kubbutat MH, Wohlenberg C, Flad HD, et al. Cell proliferation-associated nuclear antigen defined by antibody Ki-67: a new kind of cell cycle-maintaining proteins. Arch Immunol Ther Exp (Warsz). 1995;43:117\u201321.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"4485_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","volume":"182","author":"T Scholzen","year":"2000","unstructured":"Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311\u201322.","journal-title":"J Cell Physiol"},{"key":"4485_CR11","doi-asserted-by":"crossref","unstructured":"Bourdeleau P, Pokossy-Ep\u00e9e J, Hentic O, Tihy M, Awan ZA, Couvelard A, et al. Temporal increase in Ki-67 index in patients with pancreatic neuroendocrine tumours. Endocr Relat Cancer. 2025;32(3):e240321.","DOI":"10.1530\/ERC-24-0321"},{"key":"4485_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejogrb.2021.09.026","volume":"266","author":"A Travaglino","year":"2021","unstructured":"Travaglino A, Raffone A, Catena U, De Luca M, Toscano P, Del Prete E, et al. Ki67 as a prognostic marker in uterine leiomyosarcoma: a quantitative systematic review. Eur J Obstet Gynecol Reprod Biol. 2021;266:119\u201324.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"4485_CR13","doi-asserted-by":"publisher","first-page":"H2211","DOI":"10.1152\/ajpheart.00966.2011","volume":"302","author":"PA Suwanabol","year":"2012","unstructured":"Suwanabol PA, Seedial SM, Zhang F, Shi X, Si Y, Liu B, et al. TGF-\u03b2 and Smad3 modulate PI3K\/Akt signaling pathway in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2012;302:H2211\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4485_CR14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2208927120","volume":"120","author":"X Liu","year":"2023","unstructured":"Liu X, Li X, Wang S, Liu Q, Feng X, Wang W, et al. ATOH8 binds SMAD3 to induce cellular senescence and prevent Ras-driven malignant transformation. Proc Natl Acad Sci U S A. 2023;120:e2208927120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4485_CR15","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/annonc\/mdu172","volume":"25","author":"L Zhang","year":"2014","unstructured":"Zhang L, Li QX, Wu HL, Lu X, Yang M, Yu SY, et al. SNPs in the transforming growth factor-\u03b2 pathway as predictors of outcome in advanced lung adenocarcinoma with EGFR mutations treated with gefitinib. Ann Oncol. 2014;25:1584\u201390.","journal-title":"Ann Oncol"},{"key":"4485_CR16","doi-asserted-by":"crossref","unstructured":"Ni H, Zhang H, Li L, Huang H, Guo H, Zhang L, et al. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer. J Immunother Cancer. 2022;10(9):e005151.","DOI":"10.1136\/jitc-2022-005151"},{"key":"4485_CR17","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC. The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471\u20134.","journal-title":"Ann Surg Oncol"},{"key":"4485_CR18","first-page":"35","volume":"1","author":"C Fenoglio-Preiser","year":"2000","unstructured":"Fenoglio-Preiser C, Carneiro F, Correa P, Guilford P, Lambert R, Megraud F, et al. Gastric Carcinoma. 2000;1:35\u201352.","journal-title":"Gastric Carcinoma"},{"key":"4485_CR19","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1111\/jcmm.16308","volume":"25","author":"J Zou","year":"2021","unstructured":"Zou J, Li C, Jiang S, Luo L, Yan X, Huang D, et al. AMPK inhibits Smad3-mediated autoinduction of TGF-\u03b21 in gastric cancer cells. J Cell Mol Med. 2021;25:2806\u201315.","journal-title":"J Cell Mol Med"},{"key":"4485_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41598-021-04055-4","volume":"12","author":"X Cheng","year":"2022","unstructured":"Cheng X, Li D, Qi T, Sun J, Zhou T, Zheng WV. Objective to identify and verify the regulatory mechanism of DTNBP1 as a prognostic marker for hepatocellular carcinoma. Sci Rep. 2022;12:211.","journal-title":"Sci Rep"},{"key":"4485_CR21","first-page":"735","volume":"40","author":"K Li","year":"2018","unstructured":"Li K, Cao YQ, Xiao JJ, Chen H. Expression and clinical significance of TTF-1, NapsinA and Ki-67 in non-small cell lung cancer. Hebei Med J. 2018;40:735\u20138.","journal-title":"Hebei Med J"},{"key":"4485_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1470-2045(09)70262-1","volume":"11","author":"R Yerushalmi","year":"2010","unstructured":"Yerushalmi R, Woods R, Ravdin PM, Hayes MM, Gelmon KA. Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol. 2010;11:174\u201383.","journal-title":"Lancet Oncol"},{"key":"4485_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0843-7","volume":"19","author":"DM Wei","year":"2018","unstructured":"Wei DM, Chen WJ, Meng RM, Zhao N, Zhang XY, Liao DY, et al. Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients. Respir Res. 2018;19:150.","journal-title":"Respir Res"},{"key":"4485_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12022-023-09755-3","volume":"34","author":"RS La Diagnostic","year":"2023","unstructured":"La Diagnostic RS. Prognostic, and predictive role of Ki67 proliferative index in neuroendocrine and endocrine neoplasms: Past, Present, and future. Endocr Pathol. 2023;34:79\u201397.","journal-title":"Endocr Pathol"},{"key":"4485_CR25","doi-asserted-by":"crossref","unstructured":"Huynh LK, Hipolito CJ, Ten Dijke P. A Perspective on the Development of TGF-\u03b2 Inhibitors for Cancer Treatment. Biomolecules. 2019;9(11):743.","DOI":"10.3390\/biom9110743"},{"key":"4485_CR26","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.1158\/0008-5472.CAN-06-4629","volume":"67","author":"G Sekimoto","year":"2007","unstructured":"Sekimoto G, Matsuzaki K, Yoshida K, Mori S, Murata M, Seki T, et al. Reversible Smad-dependent signaling between tumor suppression and oncogenesis. Cancer Res. 2007;67:5090\u20136.","journal-title":"Cancer Res"},{"key":"4485_CR27","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1158\/0008-5472.CAN-08-4203","volume":"69","author":"K Matsuzaki","year":"2009","unstructured":"Matsuzaki K, Kitano C, Murata M, Sekimoto G, Yoshida K, Uemura Y, et al. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-\u03b2 signal in later stages of human colorectal cancer. Cancer Res. 2009;69:5321\u201330.","journal-title":"Cancer Res"},{"key":"4485_CR28","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1002\/jcp.25361","volume":"231","author":"S Majumder","year":"2016","unstructured":"Majumder S, Bhowal A, Basu S, Mukherjee P, Chatterji U, Sengupta S. Deregulated E2F5\/p38\/SMAD3 circuitry reinforces the Pro-Tumorigenic switch of TGF beta signaling in prostate cancer %J. J Cell Physiol %J. 2016;231:2482\u201392.","journal-title":"J Cell Physiol %J"},{"key":"4485_CR29","doi-asserted-by":"crossref","unstructured":"Cho SY, Ha SY, Huang S-M, Kim JH, Kang MS, Yoo H-y, et al. The prognostic significance of Smad3, Smad4, Smad3 phosphoisoform expression in esophageal squamous cell carcinoma %J Medical oncology %J. 2014;31(11):236.","DOI":"10.1007\/s12032-014-0236-9"},{"key":"4485_CR30","doi-asserted-by":"crossref","unstructured":"Yoshida K, Matsuzaki K, Murata M, Yamaguchi T, Suwa K, Okazaki K. Clinico-Pathological Importance of TGF-\u03b2\/Phospho-Smad Signaling during Human Hepatic Fibrocarcinogenesis. Cancers (Basel). 2018;10(6):183.","DOI":"10.3390\/cancers10060183"},{"key":"4485_CR31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.hbpd.2020.05.007","volume":"19","author":"Y Hori","year":"2020","unstructured":"Hori Y, Ikeura T, Yamaguchi T, Yoshida K, Matsuzaki K, Ishida M, et al. Role of phosphorylated Smad3 signal components in intraductal papillary mucinous neoplasm of pancreas. Hepatobiliary & Pancreatic Diseases International. 2020;19:581\u20139.","journal-title":"Hepatobiliary & Pancreatic Diseases International"},{"key":"4485_CR32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4251\/wjgo.v16.i1.118","volume":"16","author":"SL Lv","year":"2024","unstructured":"Lv SL, Guo P, Zou JR, Chen RS, Luo LY, Huang DQ. Prognostic significance and relationship of SMAD3 phospho-isoforms and VEGFR-1 in gastric cancer: a clinicopathological study. World J Gastrointest Oncol. 2024;16:118\u201332.","journal-title":"World J Gastrointest Oncol"},{"key":"4485_CR33","doi-asserted-by":"publisher","first-page":"e70319","DOI":"10.1002\/ctm2.70319","volume":"15","author":"X Wu","year":"2025","unstructured":"Wu X, Jin Z, Li B, Lu Y, Hou J, Yao L, et al. Deciphering of intra-tumoural heterogeneity and the interplay between metastasis-associated meta-program and myofibroblasts in gastric cancer. Clin Transl Med. 2025;15:e70319.","journal-title":"Clin Transl Med"},{"key":"4485_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114774","volume":"43","author":"H Shoji","year":"2024","unstructured":"Shoji H, Hirano H, Nojima Y, Gunji D, Shinkura A, Muraoka S, et al. Phosphoproteomic subtyping of gastric cancer reveals dynamic transformation with chemotherapy and guides targeted cancer treatment. Cell Rep. 2024;43:114774.","journal-title":"Cell Rep"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04485-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04485-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04485-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T18:06:12Z","timestamp":1768845972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04485-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4485"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04485-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7284849\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"3 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. This study involving patient participants was reviewed and approved by the Ethics Committee of Shanghai Outdo Biotech Company (Shanghai, China) (NO.: SHYJS-CP-1801009). The patients provided their written informed consent to participate in this study. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}